VRTX Jan 2026 200.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:28PM EDT. Market open.
Loading interactive chart…
- GuruFocus.com
Alpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ...
Financial Performance Aligns with Analyst Projections Despite Revenue Dip
- Zacks
CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
- Simply Wall St.
Results: Vertex Pharmaceuticals Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
© 2024 Yahoo. All rights reserved.